(Reuters) -British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and ...

A UPMC pulmonologist talks about the symptoms, explains who is most at risk for a severe infection, and tells us how ...

04. 疫苗分析师表示，海外成人疫苗接种市场空间主要产品为非免疫规划产品，而国内成人疫苗接种意识不强，未来有较大发展空间。预计带状疱疹疫苗和RSV疫苗将是国内疫苗的主要研发方向。由于老龄化的趋势，带状疱疹疫苗适龄人群不断扩大，预计未来市场规模将达到350亿元。预计百克生物和智飞生物的重组带状疱疹疫苗2024H2将逐渐放量；绿竹生物疫苗已进入三期临床阶段，预计2024H2~2025年初提交上市申请 ...

国际研究指出，一岁以下婴幼儿住院，多因为感染RSV。纪鑫表示，受到新冠影响，流行病学改变，过去几乎全年都会流行RSV，但近年转为每年8月中旬开始～11月中旬最为流行，且感染重症年龄出现延迟化，过去因1岁以下小孩最严重，过去防疫做太好，病毒几乎消失，现 ...

Medical risk-based approaches outperformed age-based strategies, even when vaccine prices were low, the study authors said.

With the flu season imminent, new COVID-19 and influenza vaccines are available. What’s new with the vaccines and when should ...

Sanofi said on Monday the U.S. Food and Drug Administration has approved a manufacturing line for its and partner AstraZeneca ...

If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients ...

GSK has revised its annual vaccine sales forecast following new guidance on RSV from the CDC. But new evidence offers new ...

In the study, co-administration of GSK's RSV vaccine Arexvy and shingles shot Shingrix elicited non-inferior immune responses ...

Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, ...

意大利《共和国报》报道，气候变化使得秋季变得越来越温暖，这会让病毒传播更加活跃。